Yuen, C., Riedell, P., Artz, A., Kosuri, S., Kelly, T., Wu, S., . . . Bishop, M. (2020). NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY. Neuro Oncol.
استشهاد بنمط شيكاغوYuen, Carlen, et al. "NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY." Neuro Oncol 2020.
MLA استشهادYuen, Carlen, et al. "NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY." Neuro Oncol 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.